Oct 23 (Reuters) – Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Aditya Soni, Christine Chen and Will Russell SYDNEY/SHANGHAI/LONDON, Oct 23 (Reuters) - Apple's first…
Oct 23 (Reuters) - Trent Ltd: * TRENT LTD - SUBSIDIARY ENTERED INTO BINDING TERM…
VIDEO SHOWS: ARCHIVE STORY: Marathon and former Olympic champion Peres Jepchirchir of Kenya has been…
Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its international…
By Marissa Davison LONDON, Oct 23 (Reuters) - US-based Lyft unit Freenow and Baidu's Apollo…
Oct 23 (Reuters) - TruAlt Bioenergy Ltd: * TRUALT BIOENERGY SEPT-QUARTER CONSOL NET PROFIT 346.8…